... Background Iatrogenic arteriovenous (AV) fistula is a rare but treatable cause of high-output heart failure that can mimic restrictive cardiomyopathy and may lead to inappropriate listing for heart transplantation. Case summary A 37-year-old man presented with 7 months of progressive pedal oedema, tense...

... restitutio ad integrum to progression to dilated cardiomyopathy and death/heart transplant (HTx). ¹ Identifying outcome predictors is of utmost clinical relevance as it could be a gatekeeper in patients’ management, possibly from a very early disease stage. The increasing number of potential...

..., modestly increasing heart rate to 75–80 bpm. She was discharged on standard immunosuppression. Eleven months after transplantation, the patient reported exertional fatigue and pulsatile headaches. Electrocardiogram (ECG) showed persistent junctional rhythm (55–60 bpm), and exercise testing demonstrated...

...   1997 ; 96 : 2069 – 77 . 10.1161/01.CIR.96.6.2069 2 Feher   A , Miller   EJ . PET myocardial blood flow for post-transplant surveillance and cardiac allograft vasculopathy in heart transplant recipients . Curr Cardiol Rep   2022 ; 24 : 1865 – 71 . 10.1007/s11886-022-01804-3 3...

... interventions. Despite significant advances in the management of ACHD, important gaps in knowledge and research remain regarding the sRV, particularly in understanding its long-term adaptation, predictors of failure, optimal medical therapy, prevention of dyssynchrony, and timing for transplant. We herewith...

... or fenestration malfunction and in case of unexplained, disproportionate hepatic congestion. Last but not least, CC is crucial for haemodynamic assessment of transplant candidacy and prior to interventions. Corresponding author. Tel: +34 06411801, fax: 081/7062501, Email: [email protected] Conflict...

... a prolonged course with underlying FMD, superior mesenteric artery dissection, multiple decompensated heart failure, and cardiogenic shock ultimately requiring a heart transplant after 2 years. Discussion Revascularization in SCAD is not well defined with limited data. The incidence of cardiogenic shock...

... and internal medicine at St Vincent’s Hospital Sydney. His interests include advanced heart failure and transplantation, interventional cardiology, and medical education. Liarna Honeysett RN, Katherine Kearney BPharm MBBS MMed, Preeti Choudhary BSc MBBS PhD, Arjun Iyer MBBS PhD, Eugene Kotlyar MBBS MD MPVD...

... [email protected]. Abstract Aims History of substance use is assessed in potential heart transplantation (HT) evaluations. The evidence base for this highly consequential practice, linking substance use disorders (SUDs) with poor post-transplantation outcomes, presents methodological limitations. We...

... [email protected]. Abstract Background Heart transplantation has become a developed and routine technique, constituting the treatment of choice in advanced heart failure when other therapies have failed. The number of transplanted patients who require transplantation of another organ in their evolution...

... the original work is properly cited. echocardiography infective endocarditis uncontrolled infective complication salvage heart transplant A 47-year-old male with a history of recurrent endocarditis, with the first event related to bicuspid aortic valve, with aortic and mitral valve replacement in 2015...

... significant issues. However, persistent coughing continued. In February 2024, she was admitted following a compatible donor alert, marking the initiation of the heart transplantation process. Following the transplant, three drainages were placed: one in the left pleura, one in the pericardium, and one...

... effective in end-stage disease, and often heart transplant (HT) is the only available option. We present a series of advanced CS cases, requiring HT, along with a review of the literature evidence in this field. Case summary Case 1: a 49-year-old man initially suspected of having arrhythmogenic...

... by heart failure worldwide is incessantly increasing, counting now over 60 million. ¹ Heart transplantation (HTx) remains the gold-standard therapeutic option in the advanced heart failure. Data from recent years show that the median survival time after HTx currently exceeds 10 years. ²...

...Matthew E Harinstein; Caterina Gandolfo; Salvatore Gruttadauria; Caterina Accardo; Gonzalo Crespo; Lisa B VanWagner; Abhinav Humar Graphical Abstract Graphical Abstract Liver transplant candidates require a detailed cardiovascular assessment, involving a multidisciplinary approach, which...

... Background Giant cell myocarditis (GCM) is an inflammatory form of acute heart failure with high rates of cardiac transplantation or death. Standard acute treatment includes multi-drug immunosuppressive regimens. There is a small but growing number of case reports utilizing rabbit anti-thymocyte globulin...

... Association . Circulation   2015 ; 132 : 1435 – 1486 . 6 OPTN/UNOS policy notice clarification to the adult heart allocation system policy language. Organ Procurement and Transplantation Network Policy and Organ Allocation guidelines. December 2016. optn.transplant.hrsa.gov . 7 Mehra   MR...

... in patients with kidney failure. This study aimed to describe national trends in the incidence, treatment, and outcomes of myocardial infarction and stroke in patients with kidney failure (i.e. on dialysis or with a kidney transplant) over a 20-year period, stratified by age and sex. Methods...

... present a case of a 51-year-old male with a history of orthotopic heart transplantation (OHTx) for GCM, who experienced recurrent GCM in the allograft, leading to progressive heart failure and the need for a second heart transplant. Case summary A 51-year-old male with a history of OHTx for GCM...

... evidence and lack of consensus on donor acceptance for heart transplant (HT), selection practices vary widely across HT centres in the USA. Similar variation likely exists on a broader scale—across countries and HT systems—but remains largely unexplored. This study characterized differences in heart donor...